SK Biopharmaceuticals. (326030.KQ) Q2 2024 Earnings

9MayConfirmed
May 22
Aug 22
Q4 2023
Q2 2024
-579.77
-344.99
-110.21
124.57

Details

Expected EPS
-33.0986282724
Actual EPS
124.5699209304
Surprise EPS
157.67
Surprise Percent
+476.36%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 124.5699209304 per share for Q2 2024.

0 Comments

Share your thoughts